Rex C. Haydon to Genetic Therapy
This is a "connection" page, showing publications Rex C. Haydon has written about Genetic Therapy.
Connection Strength
0.632
-
Gene therapy for spinal fusion. Spine J. 2005 Nov-Dec; 5(6 Suppl):250S-258S.
Score: 0.231
-
Characterization of chondrocyte scaffold carriers for cell-based gene therapy in articular cartilage repair. J Biomed Mater Res A. 2013 Dec; 101(12):3542-50.
Score: 0.097
-
BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Joint Surg Am. 2007 Jun; 89(6):1315-20.
Score: 0.065
-
Gene therapy for bone regeneration. Curr Gene Ther. 2005 Apr; 5(2):167-79.
Score: 0.056
-
Characterization of adenovirus-mediated gene transfer in rabbit flexor tendons. J Hand Surg Am. 2005 Jan; 30(1):136-41.
Score: 0.055
-
Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004 Sep; 11(17):1312-20.
Score: 0.053
-
Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine (Phila Pa 1976). 2003 Apr 15; 28(8):755-63.
Score: 0.048
-
Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells. Oncol Rep. 2014 Sep; 32(3):1013-20.
Score: 0.026